July 2009
C‐Path launches Coalition Against Major Diseases (CAMD) as a consortium with pharmaceutical companies, patient groups, FDA and NIH to address clinical trial needs in neurological diseases.
C‐Path launches Coalition Against Major Diseases (CAMD) as a consortium with pharmaceutical companies, patient groups, FDA and NIH to address clinical trial needs in neurological diseases.
